U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07465458) titled 'Radiofrequency Ablation Multicenter Observational Study in Renal Oncology Patients' on March 06.
Brief Summary: This observational study is designed to expand the current database available in the literature and the existing knowledge on the outcomes and safety of radiofrequency ablation (RFA) for the treatment of primary renal cell carcinomas in stage T1a. All interventions and subsequent follow-ups are clinical decisions are independent of the study, given its observational nature.
Study Start Date: March, 2026
Study Type: OBSERVATIONAL
Condition:
Renal Carcinoma
Intervention:
DEVICE: Radiofrequency Ablation (RFA)
Minimall...